This study aims to synthesize and evaluate the properties of diopside (CaMgSi2O6) and strontium modified diopside (CaMgSi2O6-SrO) bioceramics for potential bone regeneration applications. The substitution of strontium for calcium leads to the formation of solid solutions: Sr-CaMgSi2O6, Ca-SrMgSi2O6, and a single phase of SrMgSi2O6, along with secondary phases of Ca-Sr2MgSi2O7 and Sr2MgSi2O7. This study is the first to examine the physical and biological properties of SrMgSi2O6 and its solid solutions. Microstructural analysis reveals that the pure diopside exhibits uniformly packed fine particles, while the SrO substitution results in lattice distortion and structural damage, thus weakening the mechanical properties and biodegradation resistance. The in vitro hydroxyapatite (HAp) formation ability of CaMgSi2O6-SrO bioceramics is comprehensively investigated, revealing that the re-adsorption of Mg2+/Sr2+ is a crucial factor. Pure diopside and Sr0.25 demonstrate effective HAp formation after immersion in simulated body fluid (SBF), with Sr0.25 showing finer particles and more uniform distribution due to appropriate Sr2+ re-adsorption. In contrast, SrO-rich samples show reduced HAp formation due to excessive re-adsorption of Mg2+ and Sr2+ ions, hindering HAp nuclei development. The cell viability test reveals that SrO substitution enhances cell viability due to increased surface area and the release of beneficial ions. Overall, Sr0.25 demonstrates excellent potential for bone regeneration applications by promoting HAp uniformity.
Read full abstract